228 related articles for article (PubMed ID: 8625962)
1. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
2. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Nov; 35(47):14743-8. PubMed ID: 8942635
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of CD6 and CD6 ligand in cattle: expression of the CD6 ligand (CD166) in the autonomic nervous system of cattle and the human.
Konno A; Ahn JS; Kitamura H; Hamilton MJ; Gebe JA; Aruffo A; Davis WC
J Leukoc Biol; 2001 Jun; 69(6):944-50. PubMed ID: 11404380
[TBL] [Abstract][Full Text] [Related]
6. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
7. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mouse CD53: epitope mapping, cellular distribution and induction by T cell receptor engagement during repertoire selection.
Tomlinson MG; Hanke T; Hughes DA; Barclay AN; Scholl E; Hünig T; Wright MD
Eur J Immunol; 1995 Aug; 25(8):2201-5. PubMed ID: 7545113
[TBL] [Abstract][Full Text] [Related]
9. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
Bowen MA; Aruffo AA; Bajorath J
Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
[TBL] [Abstract][Full Text] [Related]
10. Identification of residues in CD6 which are critical for ligand binding.
Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
[TBL] [Abstract][Full Text] [Related]
11. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
Gangemi RM; Swack JA; Gaviria DM; Romain PL
J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
[TBL] [Abstract][Full Text] [Related]
12. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
[TBL] [Abstract][Full Text] [Related]
13. CD6 recognizes the neural adhesion molecule BEN.
Skonier JE; Bowen MA; Aruffo A; Bajorath J
Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
[TBL] [Abstract][Full Text] [Related]
14. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
15. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
16. A new lymphocyte surface antigen defined by a monoclonal antibody (9F3) to the T cell population expanding in MRL/Mp-lpr/lpr mice.
Dumont FJ; Habbersett RC; Nichols EA
J Immunol; 1984 Aug; 133(2):809-15. PubMed ID: 6234361
[TBL] [Abstract][Full Text] [Related]
17. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.
Sánchez-Mateos P; Cebrián M; Acevedo A; López-Botet M; De Landázuri MO; Sánchez-Madrid F
Immunology; 1989 Sep; 68(1):72-9. PubMed ID: 2807372
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the expression of a second CD6 ligand by synovial fibroblasts.
Joo YS; Singer NG; Endres JL; Sarkar S; Kinne RW; Marks RM; Fox DA
Arthritis Rheum; 2000 Feb; 43(2):329-35. PubMed ID: 10693872
[TBL] [Abstract][Full Text] [Related]
19. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
[TBL] [Abstract][Full Text] [Related]
20. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
